Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Ameren Corp a un objectif de cours consensus de $96.53, basé sur les évaluations des 17 analystes. Le plus élevé est de $114 attribué par UBS le juillet 11, 2025, et le plus bas est de $74 attribué par Barclays le mars 14, 2024. Les 3 dernières évaluations d'analystes ont été publiées par Keybanc, UBS et Barclays le juillet 16, 2025, juillet 11, 2025 et juillet 10, 2025. Avec un objectif de cours moyen de $106 entre Keybanc, UBS et Barclays, il y a une variation implicite de 6.28% upside pour Ameren Corp à partir de ces dernières évaluations d'analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/16/2025 | 4.27% | Keybanc | $103 → $104 | Maintains | Overweight | |||
07/11/2025 | 14.3% | UBS | $111 → $114 | Maintains | Buy | |||
07/10/2025 | 0.26% | Barclays | $104 → $100 | Maintains | Equal-Weight | |||
06/25/2025 | 0.26% | Goldman Sachs | $91 → $100 | Upgrade | Sell → Neutral | |||
06/18/2025 | 0.26% | Morgan Stanley | $102 → $100 | Maintains | Equal-Weight | |||
06/02/2025 | 14.3% | UBS | $113 → $114 | Maintains | Buy | |||
05/22/2025 | 2.27% | Morgan Stanley | $103 → $102 | Maintains | Equal-Weight | |||
05/14/2025 | 12.29% | Wells Fargo | $108 → $112 | Maintains | Overweight | |||
05/14/2025 | 3.27% | Keybanc | → $103 | Upgrade | Sector Weight → Overweight | |||
05/06/2025 | 4.27% | Barclays | $101 → $104 | Maintains | Equal-Weight | |||
05/05/2025 | 8.28% | BMO Capital | $106 → $108 | Maintains | Outperform | |||
04/28/2025 | 6.28% | BMO Capital | $105 → $106 | Maintains | Outperform | |||
04/23/2025 | 3.27% | Morgan Stanley | $101 → $103 | Maintains | Equal-Weight | |||
04/08/2025 | 1.26% | Barclays | $102 → $101 | Maintains | Equal-Weight | |||
03/21/2025 | 13.29% | UBS | $106 → $113 | Maintains | Buy | |||
03/20/2025 | 1.26% | Morgan Stanley | $97 → $101 | Maintains | Equal-Weight | |||
03/04/2025 | 2.27% | Barclays | $95 → $102 | Maintains | Equal-Weight | |||
02/18/2025 | 5.27% | BMO Capital | $100 → $105 | Maintains | Outperform | |||
01/30/2025 | 0.26% | BMO Capital | $94 → $100 | Maintains | Outperform | |||
01/27/2025 | -4.75% | Barclays | $88 → $95 | Downgrade | Overweight → Equal-Weight | |||
01/21/2025 | 4.27% | Evercore ISI Group | $89 → $104 | Upgrade | In-Line → Outperform | |||
12/13/2024 | -5.75% | Morgan Stanley | $86 → $94 | Maintains | Equal-Weight | |||
12/05/2024 | -1.74% | BMO Capital | $93 → $98 | Maintains | Outperform | |||
11/22/2024 | -13.78% | Morgan Stanley | $88 → $86 | Maintains | Equal-Weight | |||
10/15/2024 | -11.77% | Barclays | $77 → $88 | Maintains | Overweight | |||
09/25/2024 | -14.78% | Morgan Stanley | $81 → $85 | Maintains | Equal-Weight | |||
09/20/2024 | -3.75% | Wells Fargo | $91 → $96 | Maintains | Overweight | |||
09/19/2024 | -2.75% | Jefferies | → $97 | Initiates | → Buy | |||
09/16/2024 | -10.77% | Mizuho | $82 → $89 | Upgrade | Neutral → Outperform | |||
08/29/2024 | -12.77% | B of A Securities | $86 → $87 | Maintains | Neutral | |||
08/23/2024 | -18.79% | Morgan Stanley | $74 → $81 | Maintains | Equal-Weight | |||
08/06/2024 | -12.77% | BMO Capital | $84 → $87 | Maintains | Outperform | |||
07/24/2024 | -16.78% | JP Morgan | $79 → $83 | Maintains | Neutral | |||
07/19/2024 | -12.77% | UBS | $81 → $87 | Upgrade | Neutral → Buy | |||
06/24/2024 | -27.81% | Morgan Stanley | $76 → $72 | Maintains | Equal-Weight | |||
06/24/2024 | -19.79% | BMO Capital | $81 → $80 | Maintains | Outperform | |||
05/30/2024 | -22.8% | Barclays | $73 → $77 | Upgrade | Equal-Weight → Overweight | |||
05/28/2024 | -23.8% | Morgan Stanley | $69 → $76 | Maintains | Equal-Weight | |||
05/06/2024 | -18.79% | BMO Capital | $76 → $81 | Maintains | Outperform | |||
04/15/2024 | -26.81% | Barclays | $74 → $73 | Maintains | Equal-Weight | |||
04/11/2024 | -21.8% | B of A Securities | $77 → $78 | Maintains | Neutral | |||
04/10/2024 | -26.81% | Goldman Sachs | → $73 | Initiates | → Sell | |||
03/14/2024 | -25.81% | Barclays | $72 → $74 | Maintains | Equal-Weight | |||
02/26/2024 | -23.8% | BMO Capital | $75 → $76 | Maintains | Outperform | |||
01/17/2024 | -27.81% | Barclays | $71 → $72 | Maintains | Equal-Weight | |||
01/04/2024 | -22.8% | B of A Securities | → $77 | Downgrade | Buy → Neutral | |||
12/19/2023 | -28.81% | Barclays | $77 → $71 | Maintains | Equal-Weight | |||
12/18/2023 | -19.79% | JP Morgan | → $80 | Downgrade | Overweight → Neutral | |||
12/18/2023 | -27.81% | Mizuho | $77 → $72 | Maintains | Neutral | |||
12/15/2023 | — | Keybanc | — | Downgrade | Overweight → Sector Weight | |||
12/15/2023 | — | Evercore ISI Group | — | Downgrade | Outperform → In-Line | |||
11/30/2023 | -10.77% | JP Morgan | $90 → $89 | Maintains | Overweight | |||
11/21/2023 | -17.79% | Morgan Stanley | $80 → $82 | Maintains | Equal-Weight | |||
10/25/2023 | -19.79% | Morgan Stanley | $84 → $80 | Maintains | Equal-Weight | |||
10/24/2023 | -22.8% | Barclays | $80 → $77 | Maintains | Equal-Weight | |||
10/05/2023 | -17.79% | Keybanc | $91 → $82 | Maintains | Overweight | |||
09/21/2023 | -15.78% | Morgan Stanley | $82 → $84 | Maintains | Equal-Weight | |||
08/23/2023 | -17.79% | Morgan Stanley | $88 → $82 | Maintains | Equal-Weight | |||
08/23/2023 | -19.79% | Barclays | → $80 | Initiates | Equal-Weight → Equal-Weight | |||
08/16/2023 | -4.75% | JP Morgan | $94 → $95 | Maintains | Overweight | |||
08/11/2023 | -17.79% | Mizuho | $87 → $82 | Maintains | Neutral | |||
08/04/2023 | -5.75% | Wells Fargo | $101 → $94 | Maintains | Overweight | |||
07/21/2023 | -11.77% | Morgan Stanley | $86 → $88 | Maintains | Equal-Weight | |||
07/19/2023 | -8.76% | Keybanc | $90 → $91 | Maintains | Overweight | |||
07/07/2023 | -14.78% | Guggenheim | $89 → $85 | Maintains | Neutral | |||
06/23/2023 | -13.78% | Morgan Stanley | $90 → $86 | Maintains | Equal-Weight | |||
06/13/2023 | -7.76% | JP Morgan | $102 → $92 | Maintains | Overweight | |||
06/12/2023 | -9.77% | Keybanc | → $90 | Upgrade | Sector Weight → Overweight | |||
05/22/2023 | -9.77% | Morgan Stanley | $92 → $90 | Maintains | Equal-Weight | |||
05/16/2023 | -12.77% | Mizuho | $91 → $87 | Maintains | Neutral | |||
04/20/2023 | -7.76% | Morgan Stanley | $84 → $92 | Maintains | Equal-Weight | |||
04/19/2023 | -4.75% | JP Morgan | $102 → $95 | Maintains | Overweight | |||
04/11/2023 | -0.74% | B of A Securities | $96 → $99 | Maintains | Buy | |||
04/10/2023 | 1.26% | Wells Fargo | $97 → $101 | Maintains | Overweight | |||
04/10/2023 | -8.76% | Mizuho | $89 → $91 | Maintains | Neutral | |||
03/21/2023 | -15.78% | Morgan Stanley | $89 → $84 | Maintains | Equal-Weight | |||
03/06/2023 | -10.77% | UBS | $94 → $89 | Maintains | Neutral | |||
02/22/2023 | -10.77% | Morgan Stanley | $93 → $89 | Maintains | Equal-Weight | |||
02/17/2023 | -2.75% | Wells Fargo | $101 → $97 | Maintains | Overweight | |||
01/30/2023 | -10.77% | Mizuho | $90 → $89 | Maintains | Neutral | |||
01/23/2023 | -10.77% | Guggenheim | → $89 | Downgrade | Buy → Neutral | |||
01/23/2023 | -6.76% | Morgan Stanley | $92 → $93 | Maintains | Equal-Weight | |||
01/09/2023 | -9.77% | Mizuho | $98 → $90 | Maintains | Neutral | |||
12/15/2022 | -7.76% | Morgan Stanley | $86 → $92 | Maintains | Equal-Weight | |||
12/14/2022 | 1.26% | Wells Fargo | $93 → $101 | Maintains | Overweight | |||
11/11/2022 | -13.78% | Morgan Stanley | $80 → $86 | Maintains | Equal-Weight | |||
11/07/2022 | -9.77% | BMO Capital | $85 → $90 | Maintains | Outperform | |||
10/21/2022 | -19.79% | Morgan Stanley | $99 → $80 | Maintains | Equal-Weight | |||
10/19/2022 | -6.76% | Wells Fargo | $104 → $93 | Maintains | Overweight | |||
10/18/2022 | -6.76% | JP Morgan | $111 → $93 | Maintains | Overweight | |||
09/22/2022 | -0.74% | Morgan Stanley | $101 → $99 | Maintains | Overweight | |||
09/12/2022 | -1.74% | Mizuho | $92 → $98 | Maintains | Neutral | |||
09/09/2022 | 3.27% | BMO Capital | $98 → $103 | Maintains | Outperform |
Le dernier objectif de prix pour Ameren (NYSE:AEE) a été rapporté par Keybanc le juillet 16, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $104.00 s'attendant à ce que AEE se rise dans les 12 prochains mois (un possible changement de 4.27% upside). 29 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Ameren (NYSE:AEE) a été fournie par Keybanc, et Ameren maintenu leur note overweight.
La dernière amélioration pour Ameren Corp a eu lieu le juin 25, 2025 lorsque Goldman Sachs a augmenté leur objectif de prix à $100. Goldman Sachs avait précédemment a sell pour Ameren Corp.
La dernière réduction pour Ameren Corp a eu lieu le janvier 27, 2025 lorsque Barclays a changé leur objectif de prix de $88 à $95 pour Ameren Corp.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Ameren, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Ameren a été déposée le juillet 16, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers juillet 16, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Ameren (AEE) était un maintenu avec un objectif de prix de $103.00 à $104.00. Le prix actuel de Ameren (AEE) est de $99.74, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.